Cargando…
Customizable orthopaedic oncology implants: one institution’s experience with meeting current IRB and FDA requirements
BACKGROUND: Customizable orthopaedic implants are often needed for patients with primary malignant bone tumors due to unique anatomy or complex mechanical problems. Currently, obtaining customizable orthopaedic implants for orthopaedic oncology patients can be an arduous task involving submitting ap...
Autores principales: | Willis, Alexander R., Ippolito, Joseph A., Patterson, Francis R., Benevenia, Joseph, Beebe, Kathleen S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4932010/ https://www.ncbi.nlm.nih.gov/pubmed/27429877 http://dx.doi.org/10.1186/s40064-016-2696-1 |
Ejemplares similares
-
Results of 20 consecutive patients treated with the Repiphysis expandable prosthesis for primary malignant bone
por: Benevenia, Joseph, et al.
Publicado: (2015) -
How local IRBs view central IRBs in the US
por: Klitzman, Robert
Publicado: (2011) -
Institutional review board (IRB) and ethical issues in clinical research
por: Kim, Won Oak
Publicado: (2012) -
4186 Single IRB and the CTSI: Liaison Model for the IRB Reliance Process
por: Caldwell, Christine Sego, et al.
Publicado: (2020) -
Using single IRB consultations to meet the educational needs of investigative teams
por: Johnson, Ann R., et al.
Publicado: (2022)